Concepedia

Simon Teal

ST

Statistics

Publications

6

Citations

250

H-Index

6

Active since

2011

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Bayer (Germany)

Bayer (United States)

Simon Teal is an author at Pfizer (United Kingdom) specializing in pulmonary hypertension, medicine, and cardiovascular pharmacotherapy.

Publications per year

2011–2017

6

Publications

6

Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM Study

Victor F. Tapson, David Platt, Fang Xia et al. · The American Journal of Medicine · 2016 · 73 citations · Full text

, , +13

Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia

Gustavo A. Heresi, David Platt, Wenyi Wang et al. · BMC Pulmonary Medicine · 2017 · 41 citations · Full text

, , +13

Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: Clinical associations

Neeraj Dhaun, Jean‐Luc Vachiéry, Raymond L. Benza et al. · The Journal of Heart and Lung Transplantation · 2014 · 38 citations

, , +16

Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial

Carmine Dario Vizza, Pavel Jansa, Simon Teal et al. · BMC Cardiovascular Disorders · 2017 · 37 citations · Full text

, , +12

Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension

Julio Sandoval, Adam Torbicki, Rogério Souza et al. · Pulmonary Pharmacology & Therapeutics · 2011 · 36 citations

, , +12

1–5 of 6